A new trading day began on Monday, with Mustang Bio Inc (NASDAQ: MBIO) stock price down -5.26% from the previous day of trading, before settling in for the closing price of $0.20. MBIO’s price has ranged from $0.13 to $1.66 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 86.50%. With a float of $43.41 million, this company’s outstanding shares have now reached $47.78 million.
Let’s look at the performance matrix of the company that is accounted for 80 employees. In terms of profitability, gross margin is 52.85%, operating margin of -835.67%, and the pretax margin is -812.49%.
Mustang Bio Inc (MBIO) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Mustang Bio Inc is 9.16%, while institutional ownership is 5.94%.
Mustang Bio Inc (MBIO) Performance Highlights and Predictions
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.71 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 86.50% per share during the next fiscal year.
Mustang Bio Inc (NASDAQ: MBIO) Trading Performance Indicators
Here are Mustang Bio Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.40.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.79, a number that is poised to hit -0.11 in the next quarter and is forecasted to reach -0.35 in one year’s time.
Technical Analysis of Mustang Bio Inc (MBIO)
Mustang Bio Inc (NASDAQ: MBIO) saw its 5-day average volume 0.66 million, a negative change from its year-to-date volume of 8.75 million. As of the previous 9 days, the stock’s Stochastic %D was 25.02%. Additionally, its Average True Range was 0.02.
During the past 100 days, Mustang Bio Inc’s (MBIO) raw stochastic average was set at 2.68%, which indicates a significant decrease from 9.10% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 46.89% in the past 14 days, which was lower than the 95.24% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2367, while its 200-day Moving Average is $0.4484. Nevertheless, the first resistance level for the watch stands at $0.2087 in the near term. At $0.2283, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.2402. If the price goes on to break the first support level at $0.1772, it is likely to go to the next support level at $0.1653. Assuming the price breaks the second support level, the third support level stands at $0.1457.
Mustang Bio Inc (NASDAQ: MBIO) Key Stats
With a market capitalization of 9.48 million, the company has a total of 47,780K Shares Outstanding. Currently, annual sales are 0 K while annual income is -51,600 K. The company’s previous quarter sales were 0 K while its latest quarter income was -1,410 K.
